KOPRAN LTD Financial Ratios
KOPRAN · Healthcare · Current price ₹207.46
P/E ratio
38.9x
P/B ratio
1.7x
ROE
4.9%
ROCE
7.0%
Debt / Equity
0.10
Dividend yield
1.7%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 38.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 4.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 7.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.10 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with KOPRAN LTD's latest numbers.
KOPRAN LTD profitability
KOPRAN LTD generates a return on equity of 4.9% and a return on capital employed of 7.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.10 and a P/E of 38.9x, KOPRAN LTD is conservatively financed. Our overall business-quality score for the company is 2.4 / 10.
Understand the ratios
More on KOPRAN LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.